News
14 October 2024

EIB backs Akagera vaccine development

In:
Social projects
Region:
Middle East & Africa

Early-stage vaccine development in Rwanda by Akagera Medicines Africa will be supported by €2 million financing from EIB. The new backing will...

Exclusive subscriber content…

If you are an Uxolo subscriber, please login to continue reading

Login

Not yet a subscriber? Join us today to continue accessing content without any restrictions

View our subscription options

Or to request access to Uxolo Intelligence contact us

Request Access

You might also like


Perspective
04 October 2024

The best of all outcomes – so far

The latest World Bank outcome bond – the $225 million nine-year Amazon Reforestation-Linked Bond – is the biggest to date and yet another first. But can these highly tailored...

Interview
10 October 2024

IDB Invest’s Alvarenga talks change – all $3.5bn of it

Marisela Alvarenga, chief investment officer, Latin America and the Caribbean, at IDB Invest explains how the organisation’s recent $3.5 billion capital increase and its new...